When to Retest: Lab Monitoring During Treatment

## Why Monitoring Matters Starting a medical treatment is not a set-it-and-forget-it event. Medications affect your body in ways that require tracking over time: some effects are desired (lower blood sugar, improved testosterone levels), and some need watching (liver enzyme changes, hematocrit elevation). Lab monitoring is how your physician confirms that treatment is producing the expected benefits and catches potential issues early. Understanding when and why labs are ordered helps you stay engaged with your treatment and recognize the value of each blood draw. ## GLP-1 Weight Loss Treatment ### Baseline Labs (Before or at Treatment Start) Before starting a GLP-1 medication, a comprehensive baseline panel establishes your starting point. This typically includes fasting glucose and HbA1c, a comprehensive metabolic panel (kidney and liver function, electrolytes), a lipid panel, thyroid function (TSH), and a complete blood count. These baseline values serve two purposes: they screen for conditions that might affect treatment (such as thyroid dysfunction or kidney impairment), and they provide the reference point against which future results will be compared. ### 3-Month Follow-Up The three-month mark is the first major checkpoint. By this point, you have likely titrated to a therapeutic dose and have been on stable treatment for several weeks. Key labs to recheck include fasting glucose and HbA1c (to assess metabolic improvement), liver enzymes (ALT, AST), kidney function (BUN, creatinine), and a lipid panel (to track cardiovascular risk improvement). This is often the point where members see the first meaningful improvements in metabolic markers. HbA1c may have dropped, triglycerides may have improved, and liver enzymes may have normalized, even if the total weight lost so far feels modest. ### 6-Month Follow-Up At six months, the pattern of improvement is typically well-established. The same panel is repeated, with attention to sustained trends rather than individual values. Your physician will evaluate whether metabolic health is improving in parallel with weight loss and whether any markers need closer attention. If fasting insulin or HOMA-IR was elevated at baseline, rechecking at six months can demonstrate improvement in insulin resistance, which is one of the most important long-term health outcomes of weight loss treatment. ### Ongoing Monitoring After the first six months, lab monitoring typically shifts to every six months during active weight loss and annually once weight has stabilized and you are on a maintenance regimen. More frequent testing may be appropriate if any markers are abnormal or if your physician is adjusting your treatment. ## Testosterone Replacement Therapy (TRT) TRT requires more frequent and more specific monitoring than most treatments because of its direct effects on multiple body systems. ### Baseline Labs Before starting TRT, a comprehensive panel confirms the diagnosis and establishes baselines. This includes total and free testosterone (two morning draws on separate days), LH and FSH (to help determine the cause of low testosterone), estradiol, complete blood count (with attention to hematocrit), PSA, a comprehensive metabolic panel, and a lipid panel. ### 6-Week Follow-Up The first follow-up is at approximately six weeks after starting treatment. At this point, testosterone levels should be approaching the target range. Key labs include total and free testosterone (timed relative to injection schedule if applicable), hematocrit and hemoglobin, and estradiol. The six-week check is primarily about dose calibration. If testosterone levels are below target, the dose may be increased. If hematocrit is rising quickly, the dose may need adjustment. ### 3-Month Follow-Up At three months, a more comprehensive panel is repeated. In addition to testosterone, hematocrit, and estradiol, your physician will recheck liver function, lipids, and PSA. By this point, most members are experiencing symptom improvement (better energy, mood, libido) and the lab values should reflect steady-state levels at the current dose. ### Ongoing Monitoring Once stable, TRT monitoring continues every six months for the first one to two years, then annually. Key markers that are always checked include testosterone, hematocrit (the most common safety concern with TRT), estradiol, and PSA. If hematocrit exceeds 54 percent, your physician will discuss options: dose reduction, change in delivery method, or therapeutic phlebotomy (blood donation). This is a well-understood and manageable side effect, but it requires vigilance. ## Hair Loss Treatment Hair loss medications (finasteride and dutasteride) generally require minimal lab monitoring for otherwise healthy men. However, baseline liver function tests are sometimes ordered, and a follow-up at six to twelve months can confirm that liver enzymes remain stable. For members on dutasteride, PSA should be tested at baseline. Dutasteride can suppress PSA levels by approximately 50 percent, which can mask elevated readings if prostate screening is being performed. Your physician needs to know your baseline PSA and apply appropriate adjustment factors during treatment. ## General Principles ### Timing Matters For testosterone testing, always draw blood in the morning (7 to 10 AM) when levels peak. For fasting glucose and lipid panels, fast for 8 to 12 hours before the draw. For members on injectable testosterone, the timing of the blood draw relative to the injection matters: your physician will specify whether to draw at trough (just before the next injection) or mid-cycle. ### Trends Over Snapshots A single lab value is a snapshot. What matters more is the trend over time. An ALT of 42 (slightly above the 40 U/L reference range) is less meaningful than an ALT that has been steadily declining from 65 to 42 over six months. Your physician evaluates patterns, not isolated numbers. ### Communication Is Key If you receive lab results that seem abnormal or confusing, reach out to your Clyne care team. Your physician licensed in your state can explain what each result means in the context of your treatment and whether any adjustments are needed. Lab results are available through your dashboard, and your care team is available to walk you through them. ### Do Not Skip Labs It can be tempting to skip follow-up labs when you are feeling good and treatment seems to be working. But some of the most important things labs detect (hematocrit elevation, liver enzyme changes, worsening lipids) are asymptomatic until they become serious. The labs are there to keep you safe. They are a small investment of time that protects a much larger investment in your health.